rs80359711
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000059.4(BRCA2):c.8474delC(p.Ala2825AspfsTer38) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★★). Synonymous variant affecting the same amino acid position (i.e. A2825A) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000059.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRCA2 | ENST00000380152.8 | c.8474delC | p.Ala2825AspfsTer38 | frameshift_variant | Exon 19 of 27 | 5 | NM_000059.4 | ENSP00000369497.3 | ||
BRCA2 | ENST00000530893.7 | c.8105delC | p.Ala2702AspfsTer38 | frameshift_variant | Exon 19 of 27 | 1 | ENSP00000499438.2 | |||
BRCA2 | ENST00000614259.2 | n.*532delC | non_coding_transcript_exon_variant | Exon 18 of 26 | 2 | ENSP00000506251.1 | ||||
BRCA2 | ENST00000614259 | n.*532delC | 3_prime_UTR_variant | Exon 18 of 25 | 2 | ENSP00000506251.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Breast-ovarian cancer, familial, susceptibility to, 2 Pathogenic:4
Variant allele predicted to encode a truncated non-functional protein. -
- -
PVS1; PM2_supporting; PM5_PTC_Strong -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.8474delC (also known as 8702delC) pathogenic mutation, located in coding exon 18 of the BRCA2 gene, results from a deletion of one nucleotide at nucleotide position 8474, causing a translational frameshift with a predicted alternate stop codon. This deletion has been reported in a Scandinavian breast cancer family (Hakansson S et al., AJHG 1997, (60):1068). Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Hereditary breast ovarian cancer syndrome Pathogenic:1
This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ala2825Aspfs*38) in the BRCA2 gene. It is expected to result in an absent or disrupted protein product. This variant has been observed in individual(s) with breast and/or ovarian cancer (PMID: 9150154, 26833046, 26360800). This variant is also known as c.8702delC in the literature. ClinVar contains an entry for this variant (Variation ID: 52597). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in BRCA2 are known to be pathogenic (PMID: 20104584). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at